Conformational flexibility in mammalian 15S‐lipoxygenase: Reinterpretation of the crystallographic data

Lipoxygenases (LOXs) are a family of nonheme iron dioxygenases that catalyze the regioselective and stereospecific hydroperoxidation of polyunsaturated fatty acids, and are involved in a variety of inflammatory diseases and cancers. The crystal structure of rabbit 15S‐LOX1 that was reported by Gillmor et al. in 1997 has played key roles for understanding the properties of mammalian LOXs. In this structure, three segments, including 12 residues in the superficial α2 helix, are absent and have usually been described as “disordered.” By reinterpreting the original crystallographic data we were able to elucidate two different conformations of the molecule, both having well ordered α2 helices. Surprisingly, one molecule contained an inhibitor and the other did not, thereby adopting a closed and an open form, respectively. They differed in the conformation of the segments that were absent in the original structure, which is highlighted by a 12 Å movement of α2. Consequently, they showed a difference in the size and shape of the substrate‐binding cavity. The new model should provide new insight into the catalytic mechanism involving induced conformational change of the binding pocket. It may also be helpful for the structure‐based design of LOX inhibitors. Proteins 2008. © 2007 Wiley‐Liss, Inc.

[1]  D. Britton,et al.  Estimation of twinning parameter for twins with exactly superimposed reciprocal lattices , 1972 .

[2]  S. Dahlén,et al.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.

[3]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[4]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[5]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[6]  E. Sigal,et al.  Defining the Arachidonic Acid Binding Site of Human 15-Lipoxygenase , 1996, The Journal of Biological Chemistry.

[7]  Z Otwinowski,et al.  Crystal structure of soybean lipoxygenase L-1 at 1.4 A resolution. , 1996, Biochemistry.

[8]  M. Funk,et al.  Structure of soybean lipoxygenase L3 and a comparison with its L1 isoenzyme , 1997, Proteins.

[9]  Robert Fletterick,et al.  The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity , 1997, Nature Structural Biology.

[10]  T O Yeates,et al.  Detecting and overcoming crystal twinning. , 1997, Methods in enzymology.

[11]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[12]  K. Acharya,et al.  Analysis and characterization of data from twinned crystals. , 1999, Acta crystallographica. Section D, Biological crystallography.

[13]  B. Thiele,et al.  The diversity of the lipoxygenase family , 1999, FEBS letters.

[14]  A. Brash Lipoxygenases: Occurrence, Functions, Catalysis, and Acquisition of Substrate* , 1999, The Journal of Biological Chemistry.

[15]  R. Fletterick,et al.  Shape and Specificity in Mammalian 15-Lipoxygenase Active Site , 1999, The Journal of Biological Chemistry.

[16]  H. Kuhn Structural basis for the positional specificity of lipoxygenases. , 2000, Prostaglandins & other lipid mediators.

[17]  M. Funk,et al.  Three-dimensional structure of a purple lipoxygenase. , 2001, Journal of the American Chemical Society.

[18]  M. Bunster,et al.  Crystallization and 2.2 A resolution structure of R-phycoerythrin from Gracilaria chilensis: a case of perfect hemihedral twinning. , 2001, Acta crystallographica. Section D, Biological crystallography.

[19]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[20]  E. Oliw,et al.  Plant and fungal lipoxygenases. , 2002, Prostaglandins & other lipid mediators.

[21]  H. Kuhn,et al.  Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications. , 2002, Prostaglandins & other lipid mediators.

[22]  E. Skrzypczak‐Jankun,et al.  Inhibition of lipoxygenase by (-)-epigallocatechin gallate: X-ray analysis at 2.1 A reveals degradation of EGCG and shows soybean LOX-3 complex with EGC instead. , 2003, International journal of molecular medicine.

[23]  E. Skrzypczak‐Jankun,et al.  Structure of curcumin in complex with lipoxygenase and its significance in cancer. , 2003, International journal of molecular medicine.

[24]  E. Skrzypczak‐Jankun,et al.  Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X‐ray structure at 2.1 Å resolution , 2003, Proteins.

[25]  C. Serhan Clues for new therapeutics in osteoporosis and periodontal disease: new roles for lipoxygenases? , 2004, Expert opinion on therapeutic targets.

[26]  Rainer Wiesner,et al.  Investigations into Calcium-dependent Membrane Association of 15-Lipoxygenase-1 , 2004, Journal of Biological Chemistry.

[27]  E. Skrzypczak‐Jankun,et al.  Soybean lipoxygenase-3 in complex with 4-nitrocatechol. , 2004, Acta crystallographica. Section D, Biological crystallography.

[28]  D. Hamerman Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. , 2005, QJM : monthly journal of the Association of Physicians.

[29]  A. Brash,et al.  Insights from the X-ray Crystal Structure of Coral 8R-Lipoxygenase , 2005, Journal of Biological Chemistry.

[30]  H. Holzhütter,et al.  Structural biology of mammalian lipoxygenases: enzymatic consequences of targeted alterations of the protein structure. , 2005, Biochemical and biophysical research communications.

[31]  A. Brash,et al.  A comprehensive model of positional and stereo control in lipoxygenases. , 2005, Biochemical and biophysical research communications.

[32]  Garib N Murshudov,et al.  Intensity statistics in twinned crystals with examples from the PDB. , 2006, Acta crystallographica. Section D, Biological crystallography.

[33]  Victor A Kenyon,et al.  Novel human lipoxygenase inhibitors discovered using virtual screening with homology models. , 2006, Journal of medicinal chemistry.

[34]  H. Kuhn,et al.  Affinity labeling of the rabbit 12/15-lipoxygenase using azido derivatives of arachidonic acid. , 2006, Biochemistry.

[35]  V. Petříček,et al.  Effect of crystal freezing and small-molecule binding on internal cavity size in a large protein: X-ray and docking studies of lipoxygenase at ambient and low temperature at 2.0 A resolution. , 2006, Acta crystallographica. Section D, Biological crystallography.

[36]  Ivo Feussner,et al.  Lipoxygenases: occurrence, functions and catalysis. , 2006, Journal of plant physiology.

[37]  Johan Wouters,et al.  Structural insights into human 5-lipoxygenase inhibition: combined ligand-based and target-based approach. , 2006, Journal of medicinal chemistry.